A PHASE 2/3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC GASTRITIS WITH OR WITHOUT EOSINOPHILIC DUODENITIS

Registry ID

R668-EGE-2213

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

REGENERON PHARMACEUTICALS INC

Start date

2024-07-29

Last update

2023-03-10

Conditions

• EOSINOPHILIC GASTRITIS

View on source registry